• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr J. Mario Molina Calls for Controlling Growing Medicaid Costs

Video

Specialty drug costs represent a huge concern for Medicaid, which already represents the second largest budget in a state, according to J. Mario Molina, MD, president and chief executive officer of Molina Healthcare.

Specialty drug costs represent a huge concern for Medicaid, which already represents the second largest budget in a state, J. Mario Molina, MD, president and chief executive officer of Molina Healthcare, said in October at the National Conferences on Medicare and Medicaid, and Dual Eligibles Summit held by America’s Health Insurance Plans.

If Medicaid costs are not kept under control, states run the risk of the program’s growing budget cutting into other needed services, he explained.

“The funny thing is the government is willing to set pricing, especially on Medicare, for hospital services and physician services, but they’ve been unwilling to tackle pharmaceuticals,” Dr Molina said.

Related Videos
Leslie Fish, PharmD.
Ronesh Sinha, MD
Adam Colborn, JD
Beau Raymond, MD
Judith Alberto, MHA, RPh, BCOP, director of clinical initiatives, Community Oncology Alliance
Yuqian Liu, PharmD
Jenny Craven, PharmaD, BCPS
Kimberly Westrich, MA
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Sarah Bajorek, PhD, BCACP, MBA.
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.